PRI-004

N/A

Report date: 2023/03/12 14:49:34
NME

Base Information

Drug NamePRI-004
Drug Alias NamePRI-004
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPriavoid
China Registration ClassN/A

Develop Information

Active CompaniesPriavoid
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A